T
Terrence W. Doyle
Researcher at Bristol-Myers Squibb
Publications - 166
Citations - 3526
Terrence W. Doyle is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Lactam & Esperamicin. The author has an hindex of 32, co-authored 166 publications receiving 3443 citations. Previous affiliations of Terrence W. Doyle include Vion Pharmaceuticals, Inc..
Papers
More filters
Journal ArticleDOI
Esperamicins, a novel class of potent antitumor antibiotics. 3. Structures of esperamicins A1, A2, and A1b
Jerzy Golik,George R. Dubay,Gary S. Groenewold,Hiroshi Kawaguchi,Masataka Konishi,Bala Krishnan,Hiroaki Ohkuma,Kyoichiro Saitoh,Terrence W. Doyle +8 more
Journal ArticleDOI
Esperamicins, a novel class of potent antitumor antibiotics. 2. Structure of esperamicin X
Jerzy Golik,Jon Clardy,George R. Dubay,Gary S. Groenewold,Hiroshi Kawaguchi,Masataka Konishi,Bala Krishnan,Hiroaki Ohkuma,Kyoichiro Saitoh,Terrence W. Doyle +9 more
Journal ArticleDOI
Isolation and structure of rebeccamycin - a new antitumor antibiotic from nocardia aerocoligenes
TL;DR: The isolation and structure elucidation of rebeccamycin 1, a new antitumor agent from , is described and the NMR spectra of 1 and its peracetate 2 are discussed.
Journal ArticleDOI
Kedarcidin, a new chromoprotein antitumor antibiotic : structure elucidation of kedarcidin chromophore
John E. Leet,Daniel R. Schroeder,Hofstead Sandra J,Jerzy Golik,Kimberly L. Colson,Stella Huang,Steven E. Klohr,Terrence W. Doyle,James A. Matson +8 more
Patent
Phosphonooxy and carbonate derivatives of taxol
Yasutsugu Uedai,Henry Wong,Vittorio Farina,Amarendra B. Mikkilineni,Dolatrai M. Vyas,Terrence W. Doyle +5 more
TL;DR: The present invention is directed to novel taxol derivatives useful as anti-tumor agents and pharmaceutical formulations and methods of treating mammalian tumors with the compounds of this invention as discussed by the authors.